Clonal hematopoiesis in patients with telomere biology disorders, genomic alterations in extracutaneous juvenile xanthogranulomas, and the BCMA-CD3 bispecific antibody teclistamab in relapsed/refractory multiple myeloma
Blood Podcast
00:00
Exploring Clonal Hematopoiesis and Xanthogranuloma Genomics
This chapter discusses the impact of clonal hematopoiesis in patients with telomere biology disorders and its bearing on cancer risk. It also examines juvenile xanthogranuloma, focusing on the genomic differences between skin and extracutaneous lesions and the critical role of molecular drivers in treatment.
Transcript
Play full episode
